Sairei So

机构：JCR Pharmaceuticals (Japan)

发表论文 47 篇 · 总被引 2346 次 · h-index 22

代表论文

A Phase 2/3 Trial of Pabinafusp Alfa, IDS Fused with Anti-Human Transferrin Receptor Antibody, Targeting Neurodegeneration in MPS-II (2020 · Molecular Therapy · 被引 182)
Iduronate-2-sulfatase fused with anti-hTfR antibody, pabinafusp alfa, for MPS-II: A phase 2 trial in Brazil (2021 · Molecular Therapy · 被引 62)
Enzyme Replacement Therapy with Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis of Preclinical and Clinical Data (2021 · International Journal of Molecular Sciences · 被引 45)
Treatment of Neuronopathic Mucopolysaccharidoses with Blood–Brain Barrier-Crossing Enzymes: Clinical Application of Receptor-Mediated Transcytosis (2022 · Pharmaceutics · 被引 31)
Divergent developmental trajectories in two siblings with neuropathic mucopolysaccharidosis type II (Hunter syndrome) receiving conventional and novel enzyme replacement therapies: A case report (2021 · JIMD Reports · 被引 19)
α-L-iduronidase fused with humanized anti-human transferrin receptor antibody (lepunafusp alfa) for mucopolysaccharidosis type I: A phase 1/2 trial (2024 · Molecular Therapy · 被引 14)